| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.0M | — | +21.5% |
| Cost of Revenue | $6.2M | — | +29.8% |
| R&D Expense | $39K | — | +0.0% |
| SG&A Expense | $10.1M | — | -4.4% |
| Operating Income | -$1.5M | — | +55.1% |
| Interest Expense | $892K | — | +13.1% |
| Pre-tax Income | -$2.2M | — | +45.2% |
| Net Income | -$2.2M | — | +45.2% |
| EPS (Basic) | -$0.08 | — | +55.6% |
| EPS (Diluted) | -$0.08 | — | +55.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.2M | +13.0% | +29.2% |
| Accounts Receivable | $25.0M | -16.1% | +38.7% |
| Inventory | $9.3M | -3.4% | -25.6% |
| Current Assets | $65.0M | -2.9% | +20.3% |
| Total Assets | $91.5M | -3.2% | +7.7% |
| Current Liabilities | $37.8M | +1.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.9M | — | +202.7% |
| Financing Cash Flow | $220K | — | -93.9% |
| -5.9% |
| Long-term Debt | $25.4M | +0.4% | +1.6% |
| Total Liabilities | $60.7M | -3.2% | -4.3% |
| Stockholders' Equity | $30.8M | -3.2% | +43.1% |